**Core Concept**
Erythroderma refers to the widespread scaling and erythema of the skin, often involving more than 90% of the body surface area. It is a clinical syndrome characterized by severe skin inflammation, typically resulting from an underlying skin disease, medication, or systemic condition.

**Why the Correct Answer is Right**
Erythroderma can be caused by various underlying conditions, including psoriasis, eczema (atopic dermatitis), and cutaneous T-cell lymphoma. These conditions often lead to an intense inflammatory response, which can manifest as widespread erythema and scaling. The pathophysiology of erythroderma involves an abnormal immune response, leading to the activation of T-cells and the release of pro-inflammatory cytokines.

**Why Each Wrong Option is Incorrect**
**Option A:** Psoriasis is a common cause of erythroderma, characterized by the formation of thick, silvery scales and intense erythema. It is caused by an abnormal immune response, leading to the activation of T-cells and the release of pro-inflammatory cytokines.
**Option B:** Eczema (atopic dermatitis) is another condition that can lead to erythroderma, characterized by intense pruritus, erythema, and scaling.
**Option C:** Cutaneous T-cell lymphoma is a type of skin cancer that can cause erythroderma, characterized by widespread scaling and erythema, often accompanied by lymphadenopathy.

**Clinical Pearl / High-Yield Fact**
A key clinical feature of erythroderma is the presence of intense pruritus, which can be a significant source of discomfort for patients. Additionally, erythroderma can be associated with systemic symptoms, such as fever and malaise.

**Correct Answer: C. Mycosis fungoides is a type of cutaneous T-cell lymphoma that is not typically associated with erythroderma.